Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsIndia

Coronavirus update: COVID-19 caseload in India nears 94 lakh; recovery rate above 93%

The total coronavirus cases mounted to 93,92,919 with 41,810 new infections being reported in a day, while the death toll climbed to 1,36,696 with 496 new fatalities, the data updated at 8 am showed.

November 29, 2020 / 10:38 AM IST
Representative image

Representative image

India's COVID-19 caseload inched close to 94 lakh, while the number of people who have recuperated from the disease crossed 88 lakh pushing the national recovery rate to 93.71 percent, according to the Union Health Ministry data updated on Sunday.

The total coronavirus cases mounted to 93,92,919 with 41,810 new infections being reported in a day, while the death toll climbed to 1,36,696 with 496 new fatalities, the data updated at 8 am showed.

The active COVID-19 caseload remained below 5 lakh for the 19th consecutive day.

There are 4,53,956 active coronavirus infections in the country which comprises4.83 percent of the total caseload, the data stated.

The number of people who have recuperated from the disease surged to 88,02,267 pushing the national recovery rate to 93.71 percent,while the COVID-19 casefatality rate stands at 1.46 percent.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, and surpassed 90 lakh on November 20.

According to the ICMR, over 13.95 crore samples have been tested up to November 28 with 12,83,449 samples being tested on Saturday.
PTI
first published: Nov 29, 2020 10:22 am

stay updated

Get Daily News on your Browser
Sections